$GIL Income Statement | Understand Stock

$GIL

$40.06 -$0.27 (0.67%) Close

Financial Statements

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 28, 2025	FY2024 12 months to Dec 29, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Jan 1, 2023	FY2021 12 months to Jan 2, 2022
Net sales (note 29)
Cost of sales
Gross profit
Selling, general and administrative expenses (note 18(a))
(Impairment) Reversal of impairment of trade accounts receivable
Restructuring and acquisition-related costs (note 18)
(Impairment reversal, net of write-downs)
Gains (losses) arising from sale and leaseback transactions
Net insurance gains (note 16(f))
Restructuring and acquisition-related costs (recoveries) (note 19)
Impairment reversal
Operating income
Financial expenses, net (note 16(c))
Earnings before income taxes
Income tax expense (note 20)
Net earnings from continuing operations
Discontinued operations
Net earnings
Other comprehensive (loss) income, net of related income taxes:
Cash flow hedges (note 16(d))
Actuarial (loss) gain on employee benefit obligations (note 13(a))
Translation adjustments
Other comprehensive income
Comprehensive income
Earnings per share (note 21):
Basic (in dollars per share)
Diluted (in dollars per share)

Comments